152 related articles for article (PubMed ID: 25831820)
1. [Management of anthracycline and taxane therapy-induced symptoms for the patients with breast cancer].
Fukada I; Ito Y
Nihon Rinsho; 2015 Feb; 73 Suppl 2():548-52. PubMed ID: 25831820
[No Abstract] [Full Text] [Related]
2. Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane.
Okanami Y; Ito Y; Watanabe C; Iijima K; Iwase T; Tokudome N; Takahashi S; Hatake K
Breast Cancer; 2011 Jul; 18(3):182-8. PubMed ID: 21394515
[TBL] [Abstract][Full Text] [Related]
3. Re: Lymphopenia associated with adjuvant anthracycline/taxane regimens.
Cadoo K; Lowery M; McCaffrey J
Clin Breast Cancer; 2009 Nov; 9(4):262. PubMed ID: 19933084
[No Abstract] [Full Text] [Related]
4. Possible mechanisms behind taxane-anthracycline sequencing.
Sahin I; Ararat E; Altundag K
Lancet Oncol; 2010 Jun; 11(6):514-5. PubMed ID: 20522380
[No Abstract] [Full Text] [Related]
5. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571
[TBL] [Abstract][Full Text] [Related]
6. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.
Zelek L; Cottu P; Tubiana-Hulin M; Vannetzel JM; Chollet P; Misset JL; Chouaki N; Marty M; Gamelin E; Culine S; Dieras V; Mackenzie S; Spielmann M
J Clin Oncol; 2002 May; 20(10):2551-8. PubMed ID: 12011135
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of taxane plus anthracycline with or without cyclophosphamide in Chinese node-positive breast cancer patients: an open-label, randomized controlled trial.
Lin Y; Wang C; Huang X; Zhou X; Zhou Y; Mao F; Guan J; Song Y; Zhong Y; Xu Y; Sun Q
Breast Cancer Res Treat; 2019 Jun; 175(3):659-666. PubMed ID: 30937656
[TBL] [Abstract][Full Text] [Related]
9. Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa.
Altundag K; Altundag O; Baptista MZ; Atik MA
Breast Cancer Res Treat; 2006 May; 97(2):221. PubMed ID: 16319972
[No Abstract] [Full Text] [Related]
10. An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study.
Wang Z; Lu J; Leaw S; Hong X; Wang J; Shao Z; Hu X
Cancer Chemother Pharmacol; 2012 Feb; 69(2):515-22. PubMed ID: 21874317
[TBL] [Abstract][Full Text] [Related]
11. [Recent perspectives second-line chemotherapy for breast cancer].
Fujiuchi N; Ohokubo K; Saeki T; Sasaki Y
Gan To Kagaku Ryoho; 2005 Jan; 32(1):11-4. PubMed ID: 15675574
[TBL] [Abstract][Full Text] [Related]
12. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
13. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy.
Fumoleau P; Cortés-Funes H; Taleb AB; Chan S; Campone M; Pouget JC; Tubiana-Hulin M; Slabber CF; Caroff-Paraïso I; Alberts AS; Ben Ayed F
Am J Clin Oncol; 2009 Aug; 32(4):375-80. PubMed ID: 19487917
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
Rosenstock AS; Niu J; Giordano SH; Zhao H; Wolff AC; Chavez-MacGregor M
Cancer; 2018 Mar; 124(5):899-906. PubMed ID: 29236294
[TBL] [Abstract][Full Text] [Related]
16. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
Fornier MN; Modi S; Panageas KS; Norton L; Hudis C
Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178
[TBL] [Abstract][Full Text] [Related]
17. Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.
Castaneda CA; Gómez HL
Clin Breast Cancer; 2009 Nov; 9(4):E1-3. PubMed ID: 19933071
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.
Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354
[TBL] [Abstract][Full Text] [Related]
19. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
Vasconcelos I; Wiesske A; Schoenegg W
Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
[TBL] [Abstract][Full Text] [Related]
20. Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer.
Cespedes Feliciano EM; Chen WY; Lee V; Albers KB; Prado CM; Alexeeff S; Xiao J; Shachar SS; Caan BJ
JAMA Oncol; 2020 Feb; 6(2):264-270. PubMed ID: 31804676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
